Literature DB >> 7275807

Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities.

H Nakano, Y Matsuda, K Ito, S Ohkubo, M Morimoto, F Tomita.   

Abstract

Gilvocarcin V and gilvocarcin M, a group of antitumor antibiotics with a novel skeleton, were discovered in culture broths of Actinomycete DO-38. The producing organism, subsequently determined to be a new species and named Streptomyces gilvotanareus (NRRL 11382). Gilvocarcin V and M were isolated by ethyl acetate extraction and chromatography on silica gel. The antibiotics are active against Gram-positive bacteria and experimental tumors such as mouse sarcoma 180 and mouse leukemia P388.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275807     DOI: 10.7164/antibiotics.34.266

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

1.  Engineered biosynthesis of gilvocarcin analogues with altered deoxyhexopyranose moieties.

Authors:  Micah D Shepherd; Tao Liu; Carmen Méndez; Jose A Salas; Jürgen Rohr
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  Roles of the synergistic reductive O-methyltransferase GilM and of O-methyltransferase GilMT in the gilvocarcin biosynthetic pathway.

Authors:  Nidhi Tibrewal; Theresa E Downey; Steven G Van Lanen; Ehesan Ul Sharif; George A O'Doherty; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2012-07-19       Impact factor: 15.419

4.  Light-dependent activity of the antitumor antibiotics ravidomycin and desacetylravidomycin.

Authors:  M Greenstein; T Monji; R Yeung; W M Maiese; R J White
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Structures and biological activities of novel 4'-acetylated analogs of chrysomycins A and B.

Authors:  Shun-Ichi Wada; Ryuichi Sawa; Fumiki Iwanami; Miho Nagayoshi; Yumiko Kubota; Kiyoko Iijima; Chigusa Hayashi; Yuko Shibuya; Masaki Hatano; Masayuki Igarashi; Manabu Kawada
Journal:  J Antibiot (Tokyo)       Date:  2017-09-06       Impact factor: 2.649

6.  Rh(iii)-catalyzed synthesis of dibenzo[b,d]pyran-6-ones from aryl ketone O-acetyl oximes and quinones via C-H activation and C-C bond cleavage.

Authors:  Wei Yang; Haonan Zhang; Yu Liu; Cuiman Tang; Xiaohui Xu; Jiaqi Liu
Journal:  RSC Adv       Date:  2022-05-12       Impact factor: 4.036

7.  Baeyer-Villiger C-C bond cleavage reaction in gilvocarcin and jadomycin biosynthesis.

Authors:  Nidhi Tibrewal; Pallab Pahari; Guojun Wang; Madan K Kharel; Caleb Morris; Theresa Downey; Yanpeng Hou; Tim S Bugni; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2012-10-29       Impact factor: 15.419

8.  Inactivation of the ketoreductase gilU gene of the gilvocarcin biosynthetic gene cluster yields new analogues with partly improved biological activity.

Authors:  Tao Liu; Madan K Kharel; Lili Zhu; Samuel A Bright; Cynthia Mattingly; Val R Adams; Jürgen Rohr
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

9.  Chrysomycin A Derivatives for the Treatment of Multi-Drug-Resistant Tuberculosis.

Authors:  Fan Wu; Jing Zhang; Fuhang Song; Sanshan Wang; Hui Guo; Qi Wei; Huanqin Dai; Xiangyin Chen; Xuekui Xia; Xueting Liu; Lixin Zhang; Jin-Quan Yu; Xiaoguang Lei
Journal:  ACS Cent Sci       Date:  2020-05-04       Impact factor: 14.553

10.  Total synthesis of the antitumor natural product polycarcin V and evaluation of its DNA binding profile.

Authors:  Xiao Cai; Kevin Ng; Harmanpreet Panesar; Seong-Jin Moon; Maria Paredes; Keishi Ishida; Christian Hertweck; Thomas G Minehan
Journal:  Org Lett       Date:  2014-05-13       Impact factor: 6.005

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.